AI · 1 sources covering this

Former OpenAI Exec Raises $215 Mn to Build AI-Powered Drug Research Labs

Warp Sciences will initially focus on synthesising molecular variations for drug candidates, combining chemists, robotics, and AI models trained on laboratory experiments.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Analytics India MagazineCenter·2h ago
Former OpenAI Exec Raises $215 Mn to Build AI-Powered Drug Research Labs
Warp Sciences will initially focus on synthesising molecular variations for drug candidates, combining chemists, robotics, and AI models trained on laboratory experiments.
Read at Analytics India Magazine →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/12ee6312995c86f7bb34b30f9c76222cb3f1f49c"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Former OpenAI Exec Raises $215 Mn to Build AI-Powered Drug Research Labs"></iframe>

Former OpenAI Exec Raises $215 Mn to Build AI-Powered Drug Research Labs

How 1 sources are covering this

Former OpenAI Exec Raises $215 Mn to Build AI-Powered Drug Research Labs

More from AI

How an Engineer Is Using AI to Bridge the Accessible Education Gap

Lincoln Tech Deploys LeadSquared AI Agents Across Student Enrolment Operations

Retail investors piled into the unlisted market’s favourite stock. Regret followed

eMudhra to Exit Global SSL/TLS Certificate Business

Reader

Trust & legal

Across the network